Heterogeneity of antigenic constellation in human hepatocellular carcinoma

Abstract

Hepatocellular carcinoma is one of the primary liver malignancies responsible for over a million deaths per year worldwide (approximately 10% of all deaths in the adult age range). The diagnosis of HCC can be difficult and often requires the use of more than one microscopic technique. A retrospective study was performed on a study batch of 42 cases that died of HCC due to metastasis or other secondary complications. Tissue samples were taken in order to investigate the tumour antigenic constellation by means of IHC method using a large variety of antibodies. In situ hybridization was also performed for albumin mRNA to assess the albumin expression in some selected cases. Telomerase activity was investigated using IHC method for the hTERT catalytic subunit. A cocktail of hepatic cytokeratins (CK8, 18) combined with Hep Par-1 and associated to albumin proved to be more powerful than albumin alone in differentiating HCC and increased the value of tumour diagnosis. hTERT expression was proportionally reverse to the tumour degree of differentiation, but was independent from the expression of tumour-proliferating indexes. The heterogeneity of the antigenic constellation in hepatocellular carcinoma suggests an antigenic mosaicism, which can be expressed a synchronous or metachronous manner, depending on the tumour degree of differentiation.

Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT)

“…It is well known that the heterogeneity of the antigenic constellation in HCC suggests an antigenic mosaicism, which can be expressed as synchronous or metachronous, depending on the tumour degree of differentiation [ 37 ]. Therefore, it is important to evaluate the entire nodular volume to enhance the possibility of MVI detection in any segmental portions of the lesion that expresses mosaicism.…”

Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study

“…However, HCC is a very heterogenous disease in terms of antigenic content, which also reflects upon the biologic behavior. This mosaicism determines the aggressive nature of the tumors[ 47 ]. In the present study, only increased microvascular invasion that is a subjective parameter does not determine the absolute outcome of the tumors of the patients.…”

Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma

“…Since angiogenesis plays a fundamental role in the progression of hepatocellular carcinoma, a better characterization of intratumoral neovascularization represents a subject area with huge potential to advance our understanding on HCC behavior. In this regard, some studies are focusing on immunohistochemical assays to quantify CD34, CD31, and CD105 expression to estimate microvascular density and patterns and distinguish between benign and malignant hepatic nodules, with promising but still preliminary results [3,4].…”